A charity established to fund groundbreaking research into the treatment and prevention of brain haemorrhages and stroke is looking for a business to partner with to help achieve its vision.
The Natalie Kate Moss Trust was established in 2012 following the death of Natalie from a brain haemorrhage aged only 26.
Since its foundation, the Trust has worked closely with the University of Manchester, a world-leading stroke research centre and also where Natalie was an alumni.
Natalie Kate Moss
The Trust recently committed to raising £300,000 for the University, to fund further research into stroke and brain haemorrhage. The sum will fund the salary and running costs of a post PhD research fellow for three and a half years within the stroke research team at the recently-launched Geoffrey Jefferson Brain Research Centre.
Now, to help the Trust increase its support further, it is looking for a business to partner with. Three levels of partnership are on offer, which would involve an annual pledge of between £10,000 and £30,000.
Fiona Moss, Natalie’s sister and co-founder and trustee of the Natalie Kate Moss Trust, said: “Most of us have been affected, either directly or indirectly, by strokes and we want to work in partnership with a business that wants to help us to fund this world-class research and make a real change in the treatment and prevention of stroke worldwide.
“We also want a business partner that will see this as an opportunity to boost the team spirit of their workforce by encouraging them all to support this fantastic cause.”
Statistics from Brain Research UK, show that stroke occurs more than 100,000 times per year in the UK, once every five minutes. It is the fourth single leading cause of death in the UK, responsible for 35,000 deaths annually.
“This death rate has not changed in over 30 years, which is in stark contrast to other diseases where the death rates have dramatically improved,” said Professor Stuart Allan from the University of Manchester.
“There is currently no successful treatment for haemorrhagic stroke and this is a key area of research focus for the Manchester Stroke Group.”
To donate or find out more, visit nataliekatemoss.co.uk
